Inventor · disambiguated record
Bing Zheng
Also filed as: ZHENG BING
24 granted patents·12 pending applications·264 citations·filing 2008–2023
96Inventor score
Top patents by PatentIndex Score
36 records- 0197US8545850B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2010·Granted Oct 1, 2013·48 cites·8 claims
- 0296US8088378B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Jan 3, 2012·48 cites·5 claims
- 0395US9896506B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2015·Granted Feb 20, 2018·17 cites·27 claims
- 0495US8617559B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Dec 31, 2013·19 cites·34 claims
- 0594US8691531B2Anti-CD79B antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2011·Granted Apr 8, 2014·20 cites·9 claims
- 0694US8362213B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2010·Granted Jan 29, 2013·28 cites·53 claims
- 0792US10981987B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2017·Granted Apr 20, 2021·4 cites·26 claims
- 0892US9845355B2Humanized anti-CD79b antibodies and immunoconjugates and methods of useCHEN YVONNE·Filed 2008·Granted Dec 19, 2017·20 cites·23 claims
- 0992US8466260B2Anti-FcRH5 antibodies and immunoconjugates and methods of useELKINS KRISTI·Filed 2010·Granted Jun 18, 2013·21 cites·49 claims
- 1091USRE48558EAnti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2018·Granted May 18, 2021·2 cites·70 claims
- 1191US9360484B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Jun 7, 2016·7 cites·20 claims
- 1289US11866496B2Humanized anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2021·Granted Jan 9, 2024·1 cites·31 claims
- 1389US2024309088A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1488US10544218B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2016·Granted Jan 28, 2020·4 cites·61 claims
- 1587US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 1686US10494432B2Anti-CD79B antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Dec 3, 2019·5 cites·118 claims
- 1785US10266597B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Apr 23, 2019·3 cites·99 claims
- 1885US9017951B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Apr 28, 2015·7 cites·1 claims
- 1982US2022251197A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2022·Application pending·0 cites
- 2081US10639378B2Silvestrol antibody-drug conjugates and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·1 cites·7 claims
- 2178US10239947B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Mar 26, 2019·1 cites·80 claims
- 2278US10227412B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Granted Mar 12, 2019·1 cites·18 claims
- 2376US2020247887A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2475US9751946B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Sep 5, 2017·1 cites·96 claims
- 2573US11084877B2Anti-CLL-1 antibodies and immunoconjugatesGENENTECH INC·Filed 2019·Granted Aug 10, 2021·0 cites·5 claims
- 2669US2020079852A1Anti-cd79b antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 2763US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 2862US2009068178A1Compositions and Methods for the Treatment of Tumor of Hematopoietic OriginGENENTECH INC·Filed 2008·Application pending·0 cites
- 2961US11648315B2Silvestrol antibody-drug conjugates and methods of useGENENTECH INC·Filed 2020·Granted May 16, 2023·0 cites·24 claims
- 3056US2017362318A1Compositions and methods for the treatment of tumor hematopoietic originGENENTECH INC·Filed 2017·Application pending·0 cites
- 3151US2014030281A1Anti-cd22 antibodies and immunoconjugatesGENENTECH INC·Filed 2013·Application pending·0 cites
- 3251US2014030282A1Anti-cd79b antibodies and immunoconjugatesGENENTECH INC·Filed 2013·Application pending·0 cites
- 3349US2011206658A1Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 3448US2011070243A1Compositions and methods for the treatment of tumor of hematopoieticCROWLEY CRAIG·Filed 2010·Application pending·0 cites
- 3548US2018015179A1Anti-cd79b antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
- 3647US2017326248A1Anti-cd22 antibodies and immunoconjugatesGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bing Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →